Compare RVPHW & L Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
Loews Corp is a holding company that is supported by a variety of businesses. Its majority revenue generating subsidiary is CNA Financial Corporation, a property and casualty insurance company. CNA's services include risk management, information services, and warranty and claims administration. Loews also maintains an operation of offshore oil and gas drilling rigs through Diamond Offshore Drilling, Inc. The company engages in the transportation and storage of natural gas and natural gas liquids and gathering and processing of natural gas through Boardwalk Pipeline Partners, LP. Loews also operates a chain of hotels.